| scholarly article | Q13442814 |
| P2093 | author name string | Bo Li | |
| Xiao-Xue Qin | |||
| Ke-Wei Bi | |||
| Xu-Ge Wei | |||
| P2860 | cites work | Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain | Q24321955 |
| Tumor-associated stromal cells as key contributors to the tumor microenvironment | Q26741825 | ||
| Innate and adaptive immune cells in the tumor microenvironment | Q27008342 | ||
| Microenvironmental regulation of tumor progression and metastasis | Q29615504 | ||
| Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells | Q34354339 | ||
| Lung cancer: Biology and treatment options | Q36328370 | ||
| The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets | Q38157427 | ||
| Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial | Q38364028 | ||
| Bruton's tyrosine kinase (BTK) as a promising target in solid tumors | Q38713716 | ||
| Immunotherapy Comes of Age in Lung Cancer | Q38837496 | ||
| Lung cancer: current therapies and new targeted treatments | Q38940816 | ||
| First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. | Q39388286 | ||
| BTK Modulates p53 Activity to Enhance Apoptotic and Senescent Responses. | Q40581051 | ||
| CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients | Q42158777 | ||
| BTK blocks the inhibitory effects of MDM2 on p53 activity | Q47164914 | ||
| Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer | Q51584147 | ||
| The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment | Q57457564 | ||
| BTK: a two-faced effector in cancer and tumour suppression | Q58594085 | ||
| The Ibr-7 derivative of ibrutinib exhibits enhanced cytotoxicity against non-small cell lung cancer cells via targeting of mTORC1/S6 signaling | Q64113606 | ||
| Beyond PD-L1 Markers for Lung Cancer Immunotherapy | Q64252367 | ||
| B Cell-Based Cancer Immunotherapy. | Q64913188 | ||
| Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes | Q91005217 | ||
| Development of BTK inhibitors for the treatment of B-cell malignancies | Q91299841 | ||
| Targeting BTK in CLL: Beyond Ibrutinib | Q91560342 | ||
| Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know? | Q91645074 | ||
| The impact of systemic precision medicine and immunotherapy treatments on brain metastases | Q91709281 | ||
| Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma | Q91710727 | ||
| The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons | Q91968926 | ||
| A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms | Q92255495 | ||
| p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma | Q92757551 | ||
| A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors | Q92962904 | ||
| Immune evasion before tumour invasion in early lung squamous carcinogenesis | Q93053561 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| ggplot2 | Q326489 | ||
| limma | Q112236343 | ||
| P921 | main subject | data mining | Q172491 |
| P304 | page(s) | 424 | |
| P577 | publication date | 2020-04-15 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining | |
| P478 | volume | 10 |
Search more.